Prospective Evaluation of the Clinical Effectiveness of an Innovative Catalytic Wound Care Technology
Wounds: a compendium of clinical research and practice · 2026
DOI: 10.25270/wnds/25122 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Wounds: a compendium of clinical research and practice, 2026. Verfasst von Anna Bradford und 5 weiteren Autor:innen. Beteiligte Einrichtung: W21C, O'Brien Institute for Public Health, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; anna.bradford1@ucalgary.ca. Hauptthemen laut MEDLINE: Wound Healing, Diabetic Foot, Varicose Ulcer, Bandages.
Themen: Wundversorgung
Abstract (Originalsprache)
Background
Chronic wounds present a significant health concern due to their prolonged healing time, risk of severe complications, and the burden they place on patients, health care providers, and the health system.
Objective
To prospectively evaluate an advanced wound care treatment that delivers catalytic technology (through polymers engineered to replicate the extracellular matrix) and facilitates copper-dependent cellular signaling pathways involved in wound healing.
Methods
This interrupted time series was a multisite, within-patient controlled, clinical evaluation of the catalytic technology involving 25 participants each with at least 1 chronic wound (pressure injury, diabetic foot ulcer, or venous leg ulcer). Participants received standard wound care for 28 days (control phase), followed by 28 days with the catalytic technology replacing the primary dressing (intervention phase). Wound percent area reduction (PAR) was assessed weekly.
Results
The average wound age prior to study inclusion was 84 weeks. In the control phase, the average PAR was −1.0%. In the intervention phase, the average PAR was 56.6%, showing that the catalytic technology accelerated wound healing (total overall change, 57.6%; P < .0001; > 95% power). The catalytic technology also demonstrated a safety profile equivalent to that of current state dressings.
Conclusion
When used in combination with standard of care practices to promote wound healing, the catalytic technology was shown to be an effective tool in the treatment of chronic wounds compared with other available wound dressings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- W21C, O'Brien Institute for Public Health, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; anna.bradford1@ucalgary.ca.
- W21C, O'Brien Institute for Public Health, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
- Innovation and Business Intelligence, Alberta Health Services, Calgary, AB, Canada.
- Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada; Glenrose Rehabilitation Hospital, Alberta Health Services, Edmonton, AB, Canada.
Zitieren
APA
Bradford, A., de Grood, J., Ambler, K., Dehghan Noudeha, N., Wickson, P., & Ho, C. (2026). Prospective Evaluation of the Clinical Effectiveness of an Innovative Catalytic Wound Care Technology. Wounds: a compendium of clinical research and practice. https://doi.org/10.25270/wnds/25122
Vancouver
Bradford A, de Grood J, Ambler K, Dehghan Noudeha N, Wickson P, Ho C. Prospective Evaluation of the Clinical Effectiveness of an Innovative Catalytic Wound Care Technology. Wounds: a compendium of clinical research and practice. 2026. doi:10.25270/wnds/25122
BibTeX
@article{Bradford2026,
author = {Bradford, Anna and de Grood, Jill and Ambler, Kathryn and Dehghan Noudeha, Negar and Wickson, Patty and Ho, Chester},
title = {Prospective Evaluation of the Clinical Effectiveness of an Innovative Catalytic Wound Care Technology},
journal = {Wounds: a compendium of clinical research and practice},
year = {2026},
doi = {10.25270/wnds/25122}
}
EUVIMED